18 June 2019 in Journal of Materials Science: Materials in Electronics
6 January 2014 in Applied Physics Letters
Partial charge compensation in ferroelectric nanostructures is known to play a critical role in stabilizing equilibrium domain patterns. We use first-principles-based simulations to study the effect of partial charge compensation on the response of polarization to the electric field in PbTiO3 and BaTiO3 ultrathin films. Computational data predict that the response can be altered at the qualitative level by tailoring partial charge compensation. We report an unusual transition from ferroelectric to antiferroelectric to dielectric behavior induced by the change in the amount of compensating charge. Interestingly, films with antiferroelectric features exhibit superior potential for energy storage applications.
16 September 2020 in Recent Patents on Nanotechnology
Recent advances in nanotechnology make it possible to create nanomaterials based on γ-alumina with novel hierarchical structure and physicochemical properties. Hierarchical γ-alumina can be synthesized using chemical or physical methods. The nanostructures based on γ-alumina exhibit unique properties, which are utilized in the design of efficient applications. These superior properties are often due to their hierarchical organizations from the nanosize scale to the macroscopic level. The present review is devoted to the contemporary state of the studies on the methods to produce hierarchical γ-alumina. We tried to summarize herein the literature data on the methods of synthesis of hierarchical γ-AlOOH and γ-Al2O3 with controlled morphology and the application of these methods for the synthesis of hierarchical γ-AlOOH and γ-Al2O3 nanocomposites.
15 October 2018 in The Clinician
The aim of the work was to study the clinical case of a rare heart disease — peripartum cardiomyopathy.Materials and methods. The puerperal, 34 years old, was admitted to the regional cardiologic dispensary from the regional perinatal center after an emergency cesarean section at 37 weeks of gestation with complaints on short of breath, heaviness in the interscapular region, dyspnea at little exertion and rest, cough with light colored phlegm.Results. Based on anamnesis data (infection at the 22nd week of pregnancy), the clinical picture (symptoms of heart failure from the 36th week of gestation), instrumental research data, a clinical diagnosis was made: Peripartum cardiomyopathy. Echocardiography has become one of the main diagnostic methods that made it possible to verify the diagnosis. Dilatation of the left atrium and left ventricle, reduction of the left ventricular ejection fraction to 40 % and pulmonary hypertension were revealed. The recovery of heart systolic function occurred after 6 months (increasing of the left ventricular ejection fraction up to 58 %).Conclusion. This clinical case is interesting because this rare for Russia disease developed in the third trimester of pregnancy (according to literary data, it often occurs after childbirth). Because of the unstable patient»s condition, an emergency caesarean section was performed, that saved the life of the mother and child. Restoration of heart systolic function occurred after 6 months.
14 February 2026 in Clinical Medicine (Russian Journal)
The article presents a clinical case of the development of the pro-arrhythmogenic effect of lappaconitine hydrobromide in the form of monomorphic ventricular tachycardia in a 68-year-old female patient. Upon admission, there were complaints of a constant feeling of heaviness in the sternum and shortness of breath, episodes of dizziness and unsteadiness when walking, interruptions in the work of the heart, occurring with minor physical exertion. The patient has a history of type 2 myocardial infarction (two years ago), during inpatient treatment ventricular tachycardia was recorded, due to which amiodarone was prescribed. At the outpatient stage, amiodarone was replaced with lappaconitine hydrobromide. Three days before the current hospitalization, during Holter ECG monitoring, frequent ventricular extrasystoles, episodes of unstable and stable ventricular monomorphic tachycardia were recorded. The detected arrhythmia was assessed as a proarrhythmogenic effect of lappaconitine hydrobromide, due to which this drug was discontinued and amiodarone was prescribed. During echocardiography on the second day of hospitalization, diffuse myocardial hypokinesia was detected, a decrease in the left ventricular ejection fraction to 48%. During the treatment, an improvement in well-being was noted: chest discomfort, shortness of breath, and attacks of palpitations did not bother. One month after hospitalization, outpatient echocardiography showed an increase in the left ventricular ejection fraction to 54%. The presented case draws the attention of practicing physicians to the need to monitor the effectiveness and safety of antiarrhythmic therapy, especially in patients with organic myocardial damage.